Commonwealth Equity Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Commonwealth Equity Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	64,295 -3,454	-5%	-$110K	﹤0.01%	1856
2026 Q1	$1.79M	Sell	67,749 -4,271	-6%	-$125K	﹤0.01%	2107
2025 Q4	$2.09M	Buy	72,020 +2,303	+3%	+$69.1K	﹤0.01%	1953
2025 Q3	$1.94M	Sell	69,717 -10,091	-13%	-$255K	﹤0.01%	2019
2025 Q2	$1.94M	Sell	79,808 -35,136	-31%	-$770K	﹤0.01%	2008
2025 Q1	$2.39M	Sell	114,944 -51,752	-31%	-$1.3M	﹤0.01%	1787
2024 Q4	$3.92M	Sell	166,696 -99,359	-37%	-$2.45M	0.01%	1396
2024 Q3	$6.81M	Sell	266,055 -29,875	-10%	-$761K	0.01%	1034
2024 Q2	$6.95M	Sell	295,930 -44,184	-13%	-$1.12M	0.01%	1001
2024 Q1	$9.78M	Sell	340,114 -23,950	-7%	-$720K	0.02%	796
2023 Q4	$11.9M	Sell	364,064 -73,453	-17%	-$2M	0.02%	654
2023 Q3	$12.2M	Sell	437,517 -29,158	-6%	-$953K	0.03%	593
2023 Q2	$15.9M	Sell	466,675 -62,278	-12%	-$1.96M	0.03%	494
2023 Q1	$15.9K	Sell	528,953 -23,928	-4%	-$741K	0.03%	478
2022 Q4	$15.6M	Buy	552,881 +7,666	+1%	+$243K	0.04%	455
2022 Q3	$17.9M	Sell	545,215 -44,484	-8%	-$1.63M	0.05%	369
2022 Q2	$18.6M	Sell	589,699 -2,200	-0.4%	-$76.9K	0.05%	363
2022 Q1	$27.2M	Sell	591,899 -1,865	-0.3%	-$88.9K	0.06%	292
2021 Q4	$36.4M	Sell	593,764 -77,825	-12%	-$5.38M	0.08%	228
2021 Q3	$50.2M	Buy	671,589 +13,371	+2%	+$1.12M	0.13%	164
2021 Q2	$60.9M	Sell	658,218 -106,506	-14%	-$9.06M	0.15%	142
2021 Q1	$67.9M	Buy	764,724 +144,234	+23%	+$14.3M	0.19%	112
2020 Q4	$57.9M	Buy	620,490 +206,272	+50%	+$16.4M	0.17%	124
2020 Q3	$26.4M	Buy	414,218 +109,552	+36%	+$6.42M	0.09%	220
2020 Q2	$15.9M	Buy	304,666 +87,434	+40%	+$3.75M	0.06%	297
2020 Q1	$6.79M	Buy	217,232 +35,634	+20%	+$1.19M	0.03%	461
2019 Q4	$6.09M	Buy	181,598 +29,041	+19%	+$923K	0.02%	557
2019 Q3	$4.5M	Buy	152,557 +8,429	+6%	+$274K	0.02%	634
2019 Q2	$4.97M	Buy	144,128 +72,704	+102%	+$2.33M	0.02%	581
2019 Q1	$2.35M	Buy	71,424 +18,582	+35%	+$549K	0.01%	856
2018 Q4	$1.27M	Buy	52,842 +5,342	+11%	+$151K	0.01%	1065
2018 Q3	$1.59M	Buy	47,500 +21,939	+86%	+$694K	0.01%	1043
2018 Q2	$743K	Buy	25,561 +15,800	+162%	+$440K	﹤0.01%	1471
2018 Q1	$251K	Buy	+9,761	New	+$264K	﹤0.01%	2202

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

SFC

Strategic Financial Concepts San Antonio, Texas $336M AUM 22.98% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Commonwealth Equity Services's ARKG Position: Q2 2026 in Review

Commonwealth Equity Services reduced its ARK Genomic Revolution ETF (ARKG) stake by 5.1% in Q2 2026, selling an estimated $110K and leaving 64,295 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Commonwealth Equity Services first reported a position in ARKG in Q1 2018 and has held it in 34 quarters since. The position peaked at $67.9M in Q1 2021. 99 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Commonwealth Equity Services held 64,295 shares of ARK Genomic Revolution ETF worth $2.7M as of Q2 2026.
Commonwealth Equity Services sold 3,454 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $110K.
ARK Genomic Revolution ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1856 holding.
Commonwealth Equity Services first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 34 quarters since.
Commonwealth Equity Services's ARK Genomic Revolution ETF position peaked at $67.9M in Q1 2021.
99 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.